Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 7Lymphoid 7Myeloid 4Plasma cell 2Other neoplasm 2Classical hematology 2

Conditions

Anemia, Refractory, with Excess of Blasts 60Leukemia, Myeloid, Acute 59Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Myelodysplastic Syndromes 52Leukemia 47Leukemia, Myelomonocytic, Chronic 42Leukemia, Lymphocytic, Chronic, B-Cell 38Multiple Myeloma 36Lymphoma, Non-Hodgkin 36Leukemia, Myeloid, Chronic-Phase 35Myeloproliferative Disorders 34Hodgkin Disease 32Lymphoma 31Congenital Abnormalities 31Leukemia, Myeloid, Accelerated Phase 29Lymphoma, Follicular 28Burkitt Lymphoma 28Primary Myelofibrosis 27Lymphoma, Mantle-Cell 25Anemia, Refractory 25Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Large B-Cell, Diffuse 24Lymphoma, B-Cell, Marginal Zone 24Blast Crisis 22Anemia, Aplastic 19Myelodysplastic-Myeloproliferative Diseases 18Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 18Polycythemia Vera 17Dendritic Cell Sarcoma, Interdigitating 17Recurrence 16

Interventions

fludarabine phosphate 2fludarabine 2Melphalan 2Bone Marrow Transplantation 2thymoglobulin 1pegylated granulocyte colony-stimulating factor 1Whole-Body Irradiation 1Tacrolimus 1RFT5-SMPT-dgA immunotoxin 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Epoetin Alfa 1Cyclophosphamide 1Busulfan 1Biopsy 1Ascorbic Acid 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Lymphoid × fludarabine phosphate × Classical hematology × Clear all
NCT03670966 2026-05-04

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
30 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01499147 2018-11-08

Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

University of Illinois at Chicago

Phase NA Completed
100 enrolled 10 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Blast Crisis, Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Polycythemia Vera, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡